Euro IMAT 2020

International Meeting - Update in Antithrombotic Treatment (IMAT)

CardioTV

Sesiones

Welcome

Special lecture:
Pharmacological characteristics of parenteral antiplatelet agents

Controversy:
What is your preferred anticoagulant agent in STEMI patients?

Controversy:
Pretreatment in NSTEACS

Case-based session:
Management of antithrombotic therapy in complex PCI scenarios

Special lecture:
STEMI and cardiogenic shock: What about the antithrombotic therapy?

Special lecture:
Research in new antithrombotic agents: What’s in the pipeline?

Controversy:
Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best?

Special lecture:
Antithrombotic therapy in TAVR

Round Table discussion:
Relevant questions about antithrombotic therapy in ischemic heart disease

Case-based session:
Management of antithrombotic therapy in complex clinical scenarios

Round Table discussion:
New strategies of antithrombotic therapy in ischemic heart disease

Closure

Con la colaboración de

Logo FERRER 2020

International Meeting - Update in Antithrombotic Treatment (IMAT)

CardioTV

Sesiones

Welcome

Special lecture:
Pharmacological characteristics of parenteral antiplatelet agents

Controversy:
What is your preferred anticoagulant agent in STEMI patients?

Controversy:
Pretreatment in NSTEACS

Case-based session:
Management of antithrombotic therapy in complex PCI scenarios

Special lecture:
STEMI and cardiogenic shock: What about the antithrombotic therapy?

Special lecture:
Research in new antithrombotic agents: What’s in the pipeline?

Controversy:
Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best?

Special lecture:
Antithrombotic therapy in TAVR

Round Table discussion:
Relevant questions about antithrombotic therapy in ischemic heart disease

Case-based session:
Management of antithrombotic therapy in complex clinical scenarios

Round Table discussion:
New strategies of antithrombotic therapy in ischemic heart disease

Closure

Con la colaboración de

International Meeting - Update in Antithrombotic Treatment (IMAT)

CardioTV

Sesiones

Welcome

Special lecture:Pharmacological characteristics of parenteral antiplatelet agents

Controversy:What is your preferred anticoagulant agent in STEMI patients?

Controversy:Pretreatment in NSTEACS

Case-based session:Management of antithrombotic therapy in complex PCI scenarios

Special lecture:STEMI and cardiogenic shock: What about the antithrombotic therapy?

Special lecture:Research in new antithrombotic agents: What’s in the pipeline?

Controversy:Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best?

Special lecture:Antithrombotic therapy in TAVR

Round Table discussion:Relevant questions about antithrombotic therapy in ischemic heart disease

Case-based session:Management of antithrombotic therapy in complex clinical scenarios

Round Table discussion:New strategies of antithrombotic therapy in ischemic heart disease

Closure

Con la colaboración de

Special lecture:
Pharmacological characteristics of parenteral antiplatelet agents

Controversy:
What is your preferred anticoagulant agent in STEMI patients?

Controversy:
Pretreatment in NSTEACS

Case-based session:
Management of antithrombotic therapy in complex PCI scenarios

Special lecture:
STEMI and cardiogenic shock: What about the antithrombotic therapy?

Special lecture:
Research in new antithrombotic agents: What’s in the pipeline?

Controversy:
Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best?

Special lecture:
Antithrombotic therapy in TAVR

Round Table discussion:
Relevant questions about antithrombotic therapy in ischemic heart disease

Case-based session:
Management of antithrombotic therapy in complex clinical scenarios

Round Table discussion:
New strategies of antithrombotic therapy in ischemic heart disease